connus ou non, doivent être déclarés depuis 2011, l'apport des déclarations est bien sûr plus important pour les déclarations des EI non connus et/ou graves. L'incidence des EI non connus et/ou graves ne nous aurait pas permis d'évaluer l'adhésion des patients à cette procédure de déclaration ,
on notait 38 % d'EI graves et 22,2 % d'EI non mentionnés dans le RCP. En médecine générale, Moride et al (13) ,
Under-Reporting of Adverse Drug Reactions, Drug Safety, vol.29, issue.1, pp.385-96, 2006. ,
DOI : 10.2165/00002018-200629050-00003
Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28 Disponible sur: http://ansm.sante.fr/Declarer-un-effet-indesirable/Pharmacovigilance/Role-desdifferents-acteurs, 2016. ,
Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28 Disponible sur: http://ansm.sante.fr/Declarer-un-effet-indesirable/Votre-declaration-concerne-unmedicament/Votre-declaration-concerne-un-medicament, 2016. ,
R??actualisation de la m??thode fran??aise d???imputabilit?? des effets ind??sirables des m??dicaments, Th??rapie, vol.66, issue.6, pp.517-542, 2011. ,
DOI : 10.2515/therapie/2011073
Information du prescripteur et aide à la prescription: rôle des centres régionaux de pharmacovigilance, Presse Med, vol.29, issue.2, p.115, 2008. ,
Agence européenne des médicaments (EMA) [En ligne]. European Union website, the official EU website -European Commission, Disponible sur, 2016. ,
Pharmacovigilance fran??aise??: missions, organisation et perspectives, Th??rapie, vol.71, issue.2, pp.135-177, 2016. ,
DOI : 10.1016/j.therap.2016.02.028
Under-reporting of adverse drug reactions in general practice, British Journal of Clinical Pharmacology, vol.43, issue.2, pp.177-81, 1997. ,
DOI : 10.1046/j.1365-2125.1997.05417.x
Un an de recueil prospectif syst??matique et d???analyse des effets ind??sirables dus aux m??dicaments, aux dispositifs m??dicaux ou aux proc??dures en m??decine g??n??rale, Th??rapie, vol.67, issue.3, pp.237-279, 2012. ,
DOI : 10.2515/therapie/2012028
Incidence of serious adverse drug reactions in general practice: A prospective study, Clinical Pharmacology & Therapeutics, vol.69, issue.6, pp.458-62, 2001. ,
DOI : 10.1067/mcp.2001.116145
Ecologie des soins médicaux, carré de White, soins primaires et médecine générale, Rev Med Liege, vol.61, pp.5-6277, 2006. ,
Determinants of Under-Reporting of Adverse Drug Reactions, Drug Safety, vol.31, issue.4, pp.19-31, 2009. ,
DOI : 10.2165/00002018-200932010-00002
The Paradox of Low Prescribers who are High??Reporters: Correlates of Spontaneous Reporting??of??Adverse Drug Reactions within Primary Care, Drug Safety, vol.30, issue.10, pp.529-563, 2010. ,
DOI : 10.2165/00002018-200730100-00160
Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions, Journal of Clinical Epidemiology, vol.55, issue.9, pp.945-50, 2002. ,
DOI : 10.1016/S0895-4356(02)00450-X
Temporal trends in spontaneous reporting of unlabelled adverse drug reactions, British Journal of Clinical Pharmacology, vol.44, issue.3, pp.299-301, 1997. ,
DOI : 10.1046/j.1365-2125.1997.t01-1-00573.x
Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases, Drug Safety, vol.4, issue.4, pp.891-899, 2007. ,
DOI : 10.2165/00002018-200730100-00007
Physicians should be paid to report adverse drug reactions, experts say, Canadian Medical Association Journal, vol.184, issue.8, pp.409-419 ,
DOI : 10.1503/cmaj.109-4153
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348215
Pay doctors to report adverse events [En ligne] Australian Doctor. 2013 [consulté le 28, Disponible sur, 2016. ,
Stimulating reporting of adverse drug reactions by using a fee., BMJ, vol.300, issue.6716, pp.22-25, 1990. ,
DOI : 10.1136/bmj.300.6716.22
A small economic inducement to stimulate increased reporting of adverse drug reactions???a way of dealing with an old problem?, European Journal of Clinical Pharmacology, vol.11, issue.37, pp.381-386, 2006. ,
DOI : 10.1007/s00228-005-0072-0
La rémunération sur objectifs de santé publique: une amélioration continue en faveur de la qualité et de la pertinence des soins Bilan à 3 ans ,
Stimulating Adverse Drug Reaction Reporting, Drug Safety, vol.43, issue.14, pp.1049-55, 2003. ,
DOI : 10.2165/00002018-200326140-00005
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia???Romagna region), European Journal of Clinical Pharmacology, vol.296, issue.2, pp.237-281, 2013. ,
DOI : 10.1007/s00228-012-1321-7
Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports, European Journal of Clinical Pharmacology, vol.7, issue.5 ,
DOI : 10.1007/s00228-008-0603-6
URL : https://hal.archives-ouvertes.fr/hal-00534937
Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study, BMC Clinical Pharmacology, vol.58, issue.7, p.14, 2011. ,
DOI : 10.1007/s00228-002-0484-z
Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28, Disponible sur, p.2, 2016. ,
Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor, European Journal of Clinical Pharmacology, vol.62, issue.5, pp.505-513, 2007. ,
DOI : 10.1007/s00228-007-0270-z
Expectations for Feedback in Adverse Drug Reporting by Healthcare Professionals in the Netherlands, Drug Safety, vol.81, issue.2, pp.221-253, 2012. ,
DOI : 10.2165/11594910-000000000-00000
Reporting of Adverse Drug Reactions by General Practitioners, Drug Safety, vol.55, issue.8, pp.851-859, 2009. ,
DOI : 10.2165/11314490-000000000-00000
Improving the quality of adverse drug reaction reporting by 4th-year medical students, Pharmacoepidemiology and Drug Safety, vol.30, issue.2, pp.97-101, 2003. ,
DOI : 10.1002/pds.797
Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine, BMC Public Health, vol.31, issue.1, p.274, 2009. ,
DOI : 10.2165/00002018-200831040-00007
Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Safety, vol.34, issue.9, pp.189-96, 2015. ,
DOI : 10.1007/s40264-014-0256-6
Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting, Drug Safety, vol.45, issue.1, pp.655-65, 2012. ,
DOI : 10.1007/BF03261962
Improving reporting of adverse drug reactions: Systematic review, Clinical Epidemiology, vol.1, pp.75-92, 2009. ,
DOI : 10.2147/CLEP.S4775
Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries, Drug Safety, vol.33, issue.8, pp.409-428, 2014. ,
DOI : 10.1007/s40264-014-0162-y
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience, British Journal of Clinical Pharmacology, vol.182, issue.2, pp.148-56, 2007. ,
DOI : 10.1016/S1090-3801(02)00114-3
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities??? Views and Needs, Drug Safety, vol.13, issue.Suppl. 1, pp.1105-1116, 2016. ,
DOI : 10.1007/s40264-016-0441-x
Expériences des signalements des effets indésirables par les patients [En ligne] Assises du médicament, Disponible sur, 2011. ,
Signalement d?????v??nements ind??sirables par les patients : ??tude pilote r??alis??e avec la collaboration d???associations de patients, Th??rapie, vol.63, issue.5, pp.385-92, 2008. ,
DOI : 10.2515/therapie:2008060
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines, Drug Safety, vol.31, issue.6, pp.845-54, 2012. ,
DOI : 10.1007/BF03261980
Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting, Drug Safety, vol.33, issue.462, pp.807-825, 2012. ,
DOI : 10.1007/BF03261977
How Do Patients Contribute to Signal Detection?, Drug Safety, vol.20, issue.3, pp.199-206, 2013. ,
DOI : 10.1007/s40264-013-0021-2
Adverse Drug Reaction Reporting by Patients in the Netherlands, Drug Safety, vol.128, issue.2, pp.515-539, 2008. ,
DOI : 10.2165/00002018-200831060-00006
Adverse Drug Reaction Reporting in the UK, Drug Safety, vol.98, issue.2, pp.775-88, 2010. ,
DOI : 10.2165/11536510-000000000-00000
Evaluation of patient reporting of adverse drug reactions to the UK ???Yellow Card Scheme???: literature review, descriptive and qualitative analyses, and questionnaire surveys, Health Technology Assessment, vol.15, issue.20, pp.1-234, 2011. ,
DOI : 10.3310/hta15200
Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011, BMC Pharmacology and Toxicology, vol.83, issue.1, p.30, 2007. ,
DOI : 10.1503/cmaj.110218
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems, Drug Safety, vol.36, issue.12, pp.337-384, 2015. ,
DOI : 10.1007/s40264-015-0264-1
Consumer Reporting of Adverse Drug Reactions, Drug Safety, vol.54, issue.11, pp.1067-74, 2004. ,
DOI : 10.2165/11316680-000000000-00000
Patient reporting of adverse drug reactions in Norway 2010-13. Tidsskr Den Nor Laegeforen Tidsskr Prakt Med Ny Raekke, pp.536-576, 2015. ,
Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association, BMC Pharmacology and Toxicology, vol.10, issue.2, p.19, 2012. ,
DOI : 10.1186/1472-6904-10-16
Adverse drug reaction reported by consumers in Denmark ? compared with reports from healthcare professionals, Disponible sur, 2013. ,
Health Action International Direct Patient Reporting in the European Union A Snapshot of Reporting Systems in Seven Member States [En ligne]. [consulté le 17, 2015. ,
Information des patients sur les effets indésirables des médicaments Disponible sur: http://www.jle.com/download/med-303752- information_des_patients_sur_les_effets_indesirables_des_medicaments-- V@5ku38AAQEAADsKPo8AAAAN-a.pdf 60 Motives for reporting adverse drug reactions by patient-reporters in the Netherlands, J Pharm Clin Eur J Clin Pharmacol, vol.303466, issue.111, pp.20151143-50, 2010. ,
Patients??? motives for participating in active post-marketing surveillance, Pharmacoepidemiology and Drug Safety, vol.63, issue.2, pp.70-76, 2013. ,
DOI : 10.1002/pds.3327
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective, British Journal of Clinical Pharmacology, vol.30, issue.5, pp.806-828, 2011. ,
DOI : 10.1111/j.1365-2125.2011.03990.x
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK, Pharmacoepidemiology and Drug Safety, vol.3, issue.2, pp.523-554, 2011. ,
DOI : 10.1002/pds.2117
Women encounter ADRs more often than do men, European Journal of Clinical Pharmacology, vol.18, issue.5, pp.999-1004, 2008. ,
DOI : 10.1007/s00228-008-0494-6
Are consumers ready to take part in the Pharmacovigilance System????a Portuguese preliminary study concerning ADR reporting, European Journal of Clinical Pharmacology, vol.329, issue.7465 ,
DOI : 10.1007/s00228-015-1867-2
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy, Expert Opinion on Drug Safety, vol.59, issue.sup1, pp.21-30, 2014. ,
DOI : 10.2165/00002018-200831060-00006
Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study, Drug Safety, vol.35, issue.3, pp.267-76, 2013. ,
DOI : 10.1007/s40264-013-0028-8
Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care, Pharmacopsychiatry, vol.49, issue.02, pp.57-61, 2016. ,
DOI : 10.1055/s-0035-1569291
Déclaration des effets indésirables médicamenteux chez les médecins généralistes: pour quoi ?, 2014. ,
Peut-on optimiser le recueil et la déclaration de la iatrogénie en médecine ambulatoire compte tenu des contraintes de la pratique?: à partir d'une étude de 2380 cas de iatrogénie relevés par des médecins généralistes français [Thèse d'exercice, 2009. ,
Exploitation systématique de la iatrogénie identifiée en Médecine Générale à des fins de Pharmacovigilance [Thèse d'exercice], 2015. ,
So much post, so busy with practice--so, no time! " : a telephone survey of general practitioners' reasons for not participating in postal questionnaire surveys, Br J Gen Pr, vol.48, issue.428, pp.1067-1076, 1998. ,
Existe-t-il des éléments prédictifs de l'implication des médecins généralistes dans les thèses de recherche en médecine générale? Exercer, pp.31-33, 2012. ,
How do French GPs consider participating in primary care research: the DRIM study, Family Practice, vol.28, issue.2, pp.226-258, 2011. ,
DOI : 10.1093/fampra/cmq073
URL : https://hal.archives-ouvertes.fr/hal-00698243
Research in general practice: a survey of incentives and disincentives for research participation, Ment Health Fam Med, vol.10, issue.3, pp.163-73, 2013. ,
La démographie médicale en Région Aquitaine: situation en 2015 Conseil National de l'Ordre des Médecins Disponible sur: http://demographie.medecin.fr/sites, p.2016 ,